Search Results - "Arron, S.T."

177 Trends of skin cancer incidence following transplantation in the United States by Garrett, G.L., Arron, S.T.

Get full text

336 Development of an in vitro model of human lip skin by Arron, S.T., Gordon, M., Lee, E., Mauro, T.M.

Get full text

A randomized phase II study evaluating vismodegib as neoadjuvant treatment of basal cell carcinoma preceding Mohs micrographic surgery: results and lessons learned by Soon, S.L., Ibrahim, S.F., Arron, S.T.

Get full text

Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients by Blomberg, M., He, S.Y., Harwood, C., Arron, S.T., Demehri, S., Green, A., Asgari, M.M.

“…Summary Although tremendous progress has been made in recent years in skin cancer care for organ transplant recipients, significant gaps remain in data‐driven…”
Get full text

CERKL is upregulated in cutaneous squamous cell carcinoma and maintains cellular sphingolipids and resistance to oxidative stress by Meyer, J.M., Lee, E., Celli, A., Park, K., Cho, R., Lambert, W., Pitchford, M., Gordon, M., Tsai, K., Cleaver, J., Arron, S.T., Mauro, T.M.

“…Summary Background Ceramide kinase‐like protein (CERKL) was originally described in retinal tissue. CERKL has been shown to protect cells from oxidative…”
Get full text

Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients by Mansh, M., Binstock, M., Williams, K., Hafeez, F., Kim, J., Glidden, D., Boettger, R., Hays, S., Kukreja, J., Golden, J., Asgari, M. M., Chin‐Hong, P., Singer, J. P., Arron, S. T.

“…Voriconazole is a triazole antifungal used to prevent and treat invasive fungal infections after lung transplantation, but it has been associated with an…”
Get full text

504 CERKL expression enhances survival in cutaneous squamous cell carcinoma by Mauro, T.M., Celli, A., Cho, R., Lambert, W., Park, K., Pitchford, M., Gordon, M., Lee, E., Tsai, K.Y., Cleaver, J., Arron, S.T.

Get full text

Single-nucleotide polymorphisms in pigment genes and nonmelanoma skin cancer predisposition: a systematic review by Binstock, M., Hafeez, F., Metchnikoff, C., Arron, S.T.

“…Summary Nonmelanoma skin cancer (NMSC) is the most common cancer in the U.S.A. The two most common NMSCs are basal cell carcinoma and squamous cell carcinoma…”
Get full text

CERKL is Upregulated in Cutaneous Squamous Cell Carcinoma and Maintains Cellular Sphingolipids and Resistance to Oxidative Stress by Meyer, J M, Lee, E, Celli, A, Park, K, Cho, R, Lambert, W, Pitchford, M, Gordon, M, Tsai, K, Cleaver, J, Arron, S T, Mauro, T M

“…Ceramide Kinase-Like Protein (CERKL) was originally described in retinal tissue. CERKL has been shown to protect cells from oxidative stress, and mutations in…”
Get full text

Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature by Lowenstein, S.E., Garrett, G., Toland, A.E., Jambusaria‐Pahlajani, A., Asgari, M.M., Green, A., Engels, E.A., Arron, S.T.

“…Summary Long‐term iatrogenic immunosuppression increases the risk of cutaneous malignancies in organ transplant recipients (OTRs), particularly the…”
Get full text

Ingenol mebutate 0·015% gel is safe for short‐term treatment of actinic keratoses on the face in solid organ transplant recipients by Crow, L.D., Yuan, J.T., Aroyan, C.S., Twigg, A.R., Singer, J.P., Roll, G.R., Lazar, A.A., Arron, S.T.

Get full text

Voriconazole exposure regulates distinct cell‐cycle and terminal differentiation pathways in primary human keratinocytes by Mansh, M., Ing, L., Dimon, M., Celli, A., Mauro, T.M., Arron, S.T.

Get full text

Induction Hedgehog pathway inhibition followed by combined‐modality radiotherapy for basal cell carcinoma by Raleigh, D.R., Algazi, A., Arron, S.T., Neuhaus, I.M., Yom, S.S.

“…Summary Basal cell carcinoma (BCC), the most common cancer in the U.S.A., is treated primarily with local excision. In some cases, lesion size, location or…”
Get full text

Variants at the OCA2/HERC2 locus affect time to first cutaneous squamous cell carcinoma in solid organ transplant recipients collected using two different study designs by Wei, L., Allain, D.C., Bernhardt, M.N., Gillespie, J.L., Peters, S.B., Iwenofu, O.H., Nelson, H.H., Arron, S.T., Toland, A.E.

“…Summary Background Variants at the oculocutaneous albinism 2 (OCA2)/HECT and RLD domain containing E3 ubiquitin protein ligase 2 (HERC2) locus have been…”
Get full text

Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression‐associated keratinocyte carcinoma by Harwood, C.A., Arron, S.T., Proby, C.M., Asgari, M.M., Bouwes Bavinck, J.N., Green, A.C., Toland, A.E.

“…Linked Articles: Madeleine et al. Br J Dermatol 2017; 177:1208–1216. Harwood et al. Br J Dermatol 2017; 177:1217–1224. Lowenstein et al. Br J Dermatol 2017;…”
Get full text

Comparisons of patients’ satisfaction should take expectations into account by Dizon, M., Linos, E., Arron, S.T., Abuabara, K., Ruiz de Luzuriaga, A.M., Jin, C., Boscardin, W.J., Chren, M.‐M.

Get full text

Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey by He, S.Y., Makhzoumi, Z.H., Singer, J.P., Chin-Hong, P.V., Arron, S.T.

“…Background Fungal infections remain a substantial cause of mortality in lung transplant (LTx) recipients, yet no comprehensive consensus guidelines have been…”
Get full text

Factors affecting sunscreen use and sun avoidance in a U.S. national sample of organ transplant recipients: Sunscreen use in organ transplant recipients by Mihalis, E.L., Wysong, A., Boscardin, W.J., Tang, J.Y., Chren, M.M., Arron, S.T.

Get full text

Advanced basal cell carcinoma: how rare is the diagnosis? by AlDabagh, B.A., Arron, S.T.

“…ORIGINAL ARTICLE, p 1066…”
Get full text

Factors affecting sunscreen use and sun avoidance in a U.S. national sample of organ transplant recipients by Mihalis, E.L., Wysong, A., Boscardin, W.J., Tang, J.Y., Chren, M.M., Arron, S.T.

“…Summary Background  Organ transplant recipients have an increased risk of nonmelanoma skin cancers due to immunosuppressive therapy following transplantation…”
Get full text